Current trends in the method used for urine derivation after radical cystectomy for muscle-invasive bladder cancer


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Bladder cancer ranks 7th in the world among all malignant tumors in men and 11th in both sexes. Radical cystectomy is the gold standard of muscle-invasive bladder cancer treatment in most countries of the world. A large number of fundamentally different options for urine derivation is developed. Therefore the choice of the method of urine derivation is one of the most important and difficult in the treatment of such patients. This review covers current international articles on this topic for 2015-2018.

全文:

受限制的访问

作者简介

A. Proskokov

Central State Medical Academy of the Russian Federation President Affairs Management

Email: dr.proskokov@mail.ru
Ph.D. (med. sci.), Head of 1st Department of Urology of the Clinical hospital of the Russian Federation President Affairs Management, Moscow, Russia; e-mail: dr.proskokov@mail.ru Moscow, Russia

S. Darenkov

Central State Medical Academy of the Russian Federation President Affairs Management

Email: darenkov@list.ru
Dr. Med. Sci., Prof., Director of the Urology Clinic, Head of Department of Urology State Medical Academy of the Russian Federation President Affairs Management, Moscow, Russia; e-mail: darenkov@list.ru Moscow, Russia

A. Agabekian

Central State Medical Academy of the Russian Federation President Affairs Management

Email: dr.agabekian@mail.ru
doctor of Urology center of the Clinical hospital of the Russian Federation President Affairs Management, Moscow, Russia; e-mail: dr.agabekian@mail.ru. https://orcid.org/0000-0003-0609-3538 Moscow, Russia

A. Trofimchuk

Central State Medical Academy of the Russian Federation President Affairs Management

Email: trofimchuk.moscow@gmail.com
clinical resident of the Department Moscow, Russia

参考

  1. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., Forman D., Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. European Journal of Cancer. 2013;49:1374-1403. doi: 10.1016/j.ejca.2012.12.027.
  2. Злокачественные новообразования в России в 2014 г. (заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2016).
  3. Bono A.V., Benvenuti C., Reali L. et al. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog. Clin. Biol. Res. 1989;303:533.
  4. Clark P.E., Stein J.P., Groshen S.G., Cai J., Miranda G., Lieskovsky G., Skinner D.G. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer. 2005;104(1):36-43. doi: 10.1002/cncr.21126
  5. World Health Organization (WHO) Consensus Conference on Bladder Cancer 1, Hautmann R.E., Abol-Enein H., Hafez K., Haro I., Mansson W., Mills R.D., Montie J.D., Sagalowsky A.I., Stein J.P., Stenzl A., Studer U.E., Volkmer B.G. Urinary diversion. Urology. 2007;69(1 Suppl):17-49. doi: 10.1016/j.urology.2006.05.058.
  6. Miller D.C., Taub D.A., Dunn R.L., Montie J.E., Wei J.T. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol. 2003;169(1):105-109. doi: 10.1097/01. ju.0000039705.36504.12
  7. Figueroa A.J., Stein J.P., Dickinson M., Skinner E.C., Thangathurai D., Mikhail M.S., Boyd S.D., Lieskovsky G., Skinner D.G. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer. 1998;83(1):141-147.
  8. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16(4):1582-1587. doi: 10.1200/JCO.1998.16.4.1582
  9. Richie J., D’Amico A. Urologic oncology, 2007. doi: 10.1016/B978-0-7216-0003-1.X5001-1.
  10. Daneshmand S. Urinary Diversion, Springer International Publishing AG 2017.
  11. Daneshmand S., Ashley M.S. Continent urinary diversion in the elderly. Curr Geriatr Rep.2015;4(1):1-6.
  12. Cavdar I. Sleep and quality of life in people with ileal conduit. Scand J Urol. 2016;50(6):472-476.
  13. Ali A.S. et al. Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol. 2015;41(3):295-299.
  14. Ahmed M. Moeen et al. Health related quality of life after urinary diversion. Which technique is better? Journal of the Egyptian National Cancer Institute. 2018;30:93-97.
  15. Groeben C., Koch R. Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014. Ann Surg Oncol. 2018;25(12):3502-3509. doi: 10.1245/s10434-018-6381-1.
  16. Bachour K. et al. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018;36(3):409-416. Doi: 10.1007/ s00345-017-2169-3.
  17. Farber N.J., Nicholas J. Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer J. Bladder Cancer. 2018;4(1):113-120.
  18. Mohamed H. Zahran Chronic urinary retention after radical cystectomy and orthotopic neobladder in women: Risk factors and relation to time. Urologic Oncology: Seminars and Original Investigations. 2017;35(2017)671.e11-e16.
  19. Amini E. Long-term complications of urinary diversion. Curr Opin Urol. 2015;25(6):570-577.
  20. Richard E. Hautmann. Urinary Diversion: How Experts Divert J. Urology. 2015;85(1):233-238.
  21. Riedmiller H. Urinary diversion. ESU Course Urinary diversion. Geneva. 2001:1-12.
  22. Thomas G. Clifford et al. Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire. The Journal of Urology. 2016.
  23. Kalble T. Urinary diversion with continent umbilical stoma: Which techniques are suitable for which patients? Urologe A. 2015;54(9): 1240-1247.
  24. Skinner E.C. Continent cutaneous diversion. Curr Opin Urol. 2015;25(6):555-561.
  25. Nayak A.L. et al. Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction. Can Urol Assoc. J. 2018;12(6):181-186.
  26. Tao S. et al. Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladdercancer: A meta-analysis. Int J Surg. 2016;27:39-45.
  27. Cerruto M.A. et al. Systematic review and meta-analysis of non RCT’s on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. Eur. J. Surg. Oncol. 2016;42(3):343-360.
  28. Ziouziou I. Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis. ProgUrol. 2018;28(5):241-250.
  29. Yang L.S. et al. A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol. 2016;25(3):281-297.
  30. Crozier J., Hennessey D., Sengupta S., Bolton D., Lawrentschuk N. A Systematic Review of Ileal Conduit and Neobladder Outcomes in Primary Bladder Cancer. Urology. 2016;96:74-79. http://dx.doi.org/doi: 10.1016/j.urology.2016.06.034.
  31. Goldberg H. et al. Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison. Uro. Oncol. 2016;34(3):121.e1-7
  32. Siracusano S., Cerruto M.A., Ciciliato S. et al. Quality of life in 73 women with bladder cancer undergoing ileal orthotopic neobladder and ileal conduit: A multicentre study among long-term survivors. Eur Urol Suppl 2016;15(3);e1017.
  33. Lauridsen S.V. Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and metaanalysis of four RCTs. Syst. Rev. 2017;6(1):150. doi: 10.1186/s13643-017-0547-y.
  34. Khan M.S. et al. A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL). Eur Urol. 2016;69(4):613-621.
  35. Tang J.Q. Robotic-assisted versus open radical cystectomy in bladder cancer: A meta-analysis of four randomized controlled trails. Int. J. Med. Robot. 2018;14(1). doi: 10.1002/rcs.1867.
  36. Xia L., Wang X., Xu T., et al. Robotic versus open radical cystectomy: an updated systematic review and meta-analysis. PLoS One. 2015;10:e0121032.
  37. Wilson T.G., Guru K., Rosen R.C., Wiklund P., Annerstedt M., Bochner B.H., et al. Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. Eur Urol. 2015;67(3):363-375.
  38. Nosov A.K. et al. Laparoscopic and open radical cystectomy for bladder cancer. Vopr Onkol. 2015;61(3):352-361 (In Russian).
  39. Yuh B., Wilson T., Bochner B. et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robotassisted radical cystectomy. Eur Urol. 2015;67(3):402-422.
  40. Smith A.B., Raynor M, Amling C.L. et al. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A. 2012;22:17-21.
  41. Hussein A.A., Dibaj S., Hinata N., Field E., O’Leary K., Kuvshinoff B., et al. Development and validation of a quality assurance score for robot-assisted radical cystectomy: a 10-year analysis. Urology. 2016;97:124-129.
  42. Tan W.S. et al. In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion. Eur Urol Focus. 2017;3(2-3):273-279.
  43. Abreu A.L. et al. Robotic radical cystectomy and intracorporeal urinary diversion: The USC technique. Indian. J Urol. 2014;30(3):300- 306.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2019
##common.cookie##